In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem

Louise M. Oleksiuk, M. Hong Nguyen, Ellen G. Press, Cassaundra L. Updike, Jessica A. O'Hara, Yohei Doi, Cornelius J. Clancy, Ryan K. Shields

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We compared in vitro killing of colistin, doripenem, and sulbactam by time-kill methods against Acinetobacter baumannii isolates collected from patients before and after colistin-doripenem treatment (initial and recurrent isolates, respectively). Colistindoripenem bactericidal activity against recurrent isolates was attenuated (mean log10 kill,-5.74 versus-2.88; P=0.01) but was restored by adding sulbactam. Doripenem MICs rather than colistin MICs correlated with the activity of colistin-doripenem. Among colistin-resistant isolates, colistin-doripenem-sulbactam combinations achieved greater killing than colistin-doripenem alone (-5.65 versus-2.43; P=0.04).

Original languageEnglish
Pages (from-to)1195-1199
Number of pages5
JournalAntimicrobial agents and chemotherapy
Volume58
Issue number2
DOIs
Publication statusPublished - 01-02-2014

Fingerprint

doripenem
Colistin
Acinetobacter baumannii
Drug Combinations
Sulbactam
Pharmaceutical Preparations
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Oleksiuk, Louise M. ; Nguyen, M. Hong ; Press, Ellen G. ; Updike, Cassaundra L. ; O'Hara, Jessica A. ; Doi, Yohei ; Clancy, Cornelius J. ; Shields, Ryan K. / In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem. In: Antimicrobial agents and chemotherapy. 2014 ; Vol. 58, No. 2. pp. 1195-1199.
@article{d791d58bc0cc4b1f9de723b510e6f228,
title = "In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem",
abstract = "We compared in vitro killing of colistin, doripenem, and sulbactam by time-kill methods against Acinetobacter baumannii isolates collected from patients before and after colistin-doripenem treatment (initial and recurrent isolates, respectively). Colistindoripenem bactericidal activity against recurrent isolates was attenuated (mean log10 kill,-5.74 versus-2.88; P=0.01) but was restored by adding sulbactam. Doripenem MICs rather than colistin MICs correlated with the activity of colistin-doripenem. Among colistin-resistant isolates, colistin-doripenem-sulbactam combinations achieved greater killing than colistin-doripenem alone (-5.65 versus-2.43; P=0.04).",
author = "Oleksiuk, {Louise M.} and Nguyen, {M. Hong} and Press, {Ellen G.} and Updike, {Cassaundra L.} and O'Hara, {Jessica A.} and Yohei Doi and Clancy, {Cornelius J.} and Shields, {Ryan K.}",
year = "2014",
month = "2",
day = "1",
doi = "10.1128/AAC.01779-13",
language = "English",
volume = "58",
pages = "1195--1199",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem. / Oleksiuk, Louise M.; Nguyen, M. Hong; Press, Ellen G.; Updike, Cassaundra L.; O'Hara, Jessica A.; Doi, Yohei; Clancy, Cornelius J.; Shields, Ryan K.

In: Antimicrobial agents and chemotherapy, Vol. 58, No. 2, 01.02.2014, p. 1195-1199.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem

AU - Oleksiuk, Louise M.

AU - Nguyen, M. Hong

AU - Press, Ellen G.

AU - Updike, Cassaundra L.

AU - O'Hara, Jessica A.

AU - Doi, Yohei

AU - Clancy, Cornelius J.

AU - Shields, Ryan K.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - We compared in vitro killing of colistin, doripenem, and sulbactam by time-kill methods against Acinetobacter baumannii isolates collected from patients before and after colistin-doripenem treatment (initial and recurrent isolates, respectively). Colistindoripenem bactericidal activity against recurrent isolates was attenuated (mean log10 kill,-5.74 versus-2.88; P=0.01) but was restored by adding sulbactam. Doripenem MICs rather than colistin MICs correlated with the activity of colistin-doripenem. Among colistin-resistant isolates, colistin-doripenem-sulbactam combinations achieved greater killing than colistin-doripenem alone (-5.65 versus-2.43; P=0.04).

AB - We compared in vitro killing of colistin, doripenem, and sulbactam by time-kill methods against Acinetobacter baumannii isolates collected from patients before and after colistin-doripenem treatment (initial and recurrent isolates, respectively). Colistindoripenem bactericidal activity against recurrent isolates was attenuated (mean log10 kill,-5.74 versus-2.88; P=0.01) but was restored by adding sulbactam. Doripenem MICs rather than colistin MICs correlated with the activity of colistin-doripenem. Among colistin-resistant isolates, colistin-doripenem-sulbactam combinations achieved greater killing than colistin-doripenem alone (-5.65 versus-2.43; P=0.04).

UR - http://www.scopus.com/inward/record.url?scp=84893488589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893488589&partnerID=8YFLogxK

U2 - 10.1128/AAC.01779-13

DO - 10.1128/AAC.01779-13

M3 - Article

C2 - 24247139

AN - SCOPUS:84893488589

VL - 58

SP - 1195

EP - 1199

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -